REINSTATE YOUR SUBSCRIPTION AND SAVE $400For over 25 years, Generic Line has been the leading resource of accurate, up-to-date news and analysis on FDA policies affecting generic drugs and drug patents. Each bi-weekly issue keeps you and your firm up to date on crucial regulatory, legislative and business changes, including the latest on:
Plus in every issue you get links to key documents, such as FDA guidances, warning letters, rules, full texts of proposed legislation and more. Biweekly, 24 issues/year, Electronic delivery. |
BonusRenew Generic Line today and receive a FREE copy of our management report, Expediting the FDA Generic Drug Approval Process – a $397 Value! Plus receive a FREE copy of our webinar CD, Impact of GDUFA Performance Metrics on ANDA Risks and Practical Considerations — a $287 Value! Key BenefitsLINKS TO KEY DOCUMENTS — Each issue provides you with links that support GEN's articles such as FDA guidances, warning letters, rules, full texts of proposed legislation and more. FDANEWS DRUG DAILY BULLETIN — This daily email brings you important FDA and international regulatory, legislative and business news in the pharmaceutical industry. ONLINE ACCESS — Consider our newsletter archive your personal library! Search your current issue — and hundreds of past issues — by keyword and relevancy. |